DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Generic: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Aurobindo Pharma LimitedManufacturer
OPHTHALMICRoute
DORZOLAMIDE HYDROCHLORIDEActive Substance
2021-05-14Original Approval

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is FDA application ANDA207629, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2026-07-22
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro La

Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.

Top Reported Reactions

1
DRUG INEFFECTIVE
172 reports
2
GLAUCOMA
92 reports
3
TREATMENT FAILURE
92 reports
4
DRUG INTOLERANCE
78 reports
5
BRONCHITIS
77 reports
6
DIVERTICULITIS
75 reports
7
COLITIS MICROSCOPIC
72 reports
8
SYNOVITIS
72 reports
9
DRUG HYPERSENSITIVITY
70 reports
10
GAIT DISTURBANCE
67 reports